Follow
Alexandra LJ Freeman
Alexandra LJ Freeman
Verified email at cam.ac.uk
Title
Cited by
Cited by
Year
Risk perceptions of COVID-19 around the world
S Dryhurst, CR Schneider, J Kerr, ALJ Freeman, G Recchia, ...
COVID-19, 162-174, 2022
19242022
Susceptibility to misinformation about COVID-19 around the world
J Roozenbeek, CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, ...
Royal Society open science 7 (10), 201199, 2020
12032020
Communicating uncertainty about facts, numbers and science
AM Van Der Bles, S Van Der Linden, ALJ Freeman, J Mitchell, AB Galvao, ...
Royal Society open science 6 (5), 181870, 2019
3292019
The effects of communicating uncertainty on public trust in facts and numbers
AM Van Der Bles, S van der Linden, ALJ Freeman, DJ Spiegelhalter
Proceedings of the National Academy of Sciences 117 (14), 7672-7683, 2020
2422020
COVID-19 risk perception: a longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom
CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, G Recchia, ...
Journal of Risk Research 24 (3-4), 294-313, 2021
1992021
Effect of information about COVID-19 vaccine effectiveness and side effects on behavioural intentions: two online experiments
JR Kerr, ALJ Freeman, TM Marteau, S van der Linden
Vaccines 9 (4), 379, 2021
1302021
How accurate are accuracy-nudge interventions? A preregistered direct replication of Pennycook et al.(2020)
J Roozenbeek, ALJ Freeman, S van der Linden
Psychological science 32 (7), 1169-1178, 2021
1292021
Five rules for evidence communication
M Blastland, ALJ Freeman, S van der Linden, TM Marteau, ...
Nature 587 (7834), 362-364, 2020
1112020
Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys
JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, ...
BMJ open 11 (8), e048025, 2021
942021
How to communicate evidence to patients
ALJ Freeman
Drug and therapeutics bulletin 57 (8), 119-124, 2019
592019
Risk communication in tables versus text: a registered report randomized trial on ‘fact boxes'
C Brick, M McDowell, ALJ Freeman
Royal Society Open Science 7 (3), 190876, 2020
502020
First authentic capture of a coelacanth, Latimeria chalumnae (Pisces: Latimeriidae), off Madagascar
PC Heemstra
S Afr J Sci 92, 150, 1996
351996
Predictors of COVID-19 vaccine acceptance across time and countries
JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, ...
MedRxiv, 2020.12. 09.20246439, 2020
332020
How well did experts and laypeople forecast the size of the COVID-19 pandemic?
G Recchia, ALJ Freeman, D Spiegelhalter
PloS one 16 (5), e0250935, 2021
312021
Recommendations for designing genetic test reports to be understood by patients and non-specialists
GD Farmer, H Gray, G Chandratillake, FL Raymond, ALJ Freeman
European Journal of Human Genetics 28 (7), 885-895, 2020
312020
Winners and losers: communicating the potential impacts of policies
C Brick, ALJ Freeman, S Wooding, WJ Skylark, TM Marteau, ...
Palgrave Communications 4 (1), 1-13, 2018
312018
Visualising SARS-CoV-2 transmission routes and mitigations
H Rutter, S Parker, W Stahl-Timmins, C Noakes, A Smyth, R Macbeth, ...
bmj 375, 2021
262021
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis
C Jackson, ALJ Freeman, Z Szlamka, DJ Spiegelhalter
PloS one 16 (2), e0246441, 2021
262021
Teaching clinicians shared decision making and risk communication online: an evaluation study
TC Hoffmann, C Del Mar, R Santhirapala, A Freeman
BMJ evidence-based medicine 26 (5), 253-253, 2021
252021
Communicating personalized risks from COVID-19: guidelines from an empirical study
ALJ Freeman, J Kerr, G Recchia, CR Schneider, ACE Lawrence, ...
Royal Society open science 8 (4), 201721, 2021
252021
The system can't perform the operation now. Try again later.
Articles 1–20